Login
$SKYE
$1.07 -$0.03 (2.29%) Live

$SKYE SEC Filings

Filed On Filing
13 Nov 2026 10-Q
12 Nov 2026 DEFA14A
12 Nov 2026 8-K: Other Events

As previously disclosed in Part II, Item 1 of the Quarterly Report on Form 10-Q filed by Skye Bioscience, Inc. (the “Company”) with the Securities and Exchange Commission on August 14, 2026, a former employee of the Company filed a lawsu...

28 Oct 2026 PRER14A
26 Oct 2026 PREM14A
14 Oct 2026 SCHEDULE 13G
24 Sep 2026 Form 4: Schwab Andrew J., Director

Sold 28,700 shares ($47.4K) · Sold 119,379 shares ($192K)

24 Sep 2026 SCHEDULE 13D/A
24 Sep 2026 Form 4: 5AM Partners VII, Llc, 10% owner and 7 others

Sold 28,700 shares ($47.4K) · Sold 119,379 shares ($192K)

18 Sep 2026 Form 4: Schwab Andrew J., Director

Sold 33,892 shares ($64.7K)

18 Sep 2026 Form 4: 5AM Partners VII, Llc, 10% owner and 7 others

Sold 33,892 shares ($64.7K)

11 Sep 2026 DEFA14A
11 Sep 2026 8-K: Termination of a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more

On September 8, 2026, in connection with the resignation of John P. Sharp as Chief Financial Officer and principal financial and accounting officer of Skye Bioscience, Inc., a Nevada corporation (the “Company”), the Company provided writ...

24 Aug 2026 DEFA14A
24 Aug 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities

***Certain identified information has been excluded from the exhibit because it both (i) is not material and (ii) is the type that the company treats as private or confidential. Such omitted information is indicated by brackets (“[***]”)...

20 Aug 2026 Form 4: Schwab Andrew J., Director

Sold 300,000 shares ($114K) · Sold 68,140 shares ($23.8K) · Sold 7,700 shares ($2.46K)

20 Aug 2026 Form 4: 5AM Partners VII, Llc, 10% owner and 7 others

Sold 300,000 shares ($114K) · Sold 68,140 shares ($23.8K) · Sold 7,700 shares ($2.46K)

20 Aug 2026 DEFA14A
20 Aug 2026 8-K/A: Material Modification to Rights of Security Holders

The previously disclosed Certificate will become effective at 12:01 am New York time on Thursday, August 24, 2026, with the Company’s common stock to begin trading on The Nasdaq Stock Market LLC on a split-adjusted basis at market open o...

18 Aug 2026 SCHEDULE 13D/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support